Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet- and streptozotocin-induced type 2 diabetes in rats

Journal of Ethnopharmacology

Volumn 199, Issue , 2017, Pages 119-127

  Jiao, Yukun ^a,b,c   Wang, Xueqian ^a   Jiang, Xiang ^a   Kong, Fansheng ^a   Wang, Shumei ^b,c   Yan, Chunyan ^a,b,c  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b Key Lab of Digital Quality Evaluation of Chinese Materia Medica of State Administration of TCM   (China)

^c Engineering Technology Research Center for Chinese Materia Medica Quality of the Universities of Guangdong Provinc   (China)

Author keywords

Antidiabetic activity; Antihyperlipidemia; Morus alba L.; Mulberry; Polysaccharides; Type 2 diabetic rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCATED SERUM PROTEIN; GLYCOSYLATED PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; LIVER PROTECTIVE AGENT; METFORMIN; MFP 50; MFP 90; MULBERRY EXTRACT; PLASMA PROTEIN; POLYSACCHARIDE; PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PLANT EXTRACT; STREPTOZOCIN;

ACUTE TOXICITY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DRUG MECHANISM; FRUIT; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; HYPOLIPEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER FUNCTION; LIVER PROTECTION; MALE; MORUS ALBA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS; PANCREAS TISSUE; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; ISOLATION AND PURIFICATION; METABOLISM; MORUS; PATHOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; FRUIT; HYPOGLYCEMIC AGENTS; MALE; MORUS; PLANT EXTRACTS; POLYSACCHARIDES; RATS; RATS, WISTAR; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 85011649909     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2017.02.003     Document Type: Article

References (37)

1. Al Qahtani, M., Al Backer, T., Al Anazi, T., Al Johani, N., Binsalih, S., AlGobain, M., Alshammari, H., Impact of lipid disorders on mortality among Saudi patients with heart failure. J. Saudi. Heart Assoc. 27 (2015), 91–95.
2. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37 (2014), S81–S90.
3. American Diabetes Association, Approaches to glycemic treatment. Diabetes Care 38 (2015), S41–S48.
4. Bello, N.A., Pfeffer, M.A., Skali, H., McGill, J.B., Rossert, J., Olson, K.A., Weinrauch, L., Cooper, M.E., de Zeeuw, D., Rossing, P., McMurray, J.J.V., Solomon, S.D., Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Res. Care, 2, 2014, e11.
5. Bogan, J.S., Hendon, N., Mckee, A.E., Tsao, T.S., Lodish, H.F., Functional cloning of TUG as a regulator of GLUT4 glucose transporter trafficking. Nature 425 (2003), 727–733.
6. Castelli, W.P., Doyle, J.T., Gordon, T., Hames, C.G., Hjortland, M.C., Hulley, S.B., Kagan, A., Zukel, W.J., HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55 (1977), 767–772.
7. Chinese Pharmacopoeia Commission, The Pharmacopoeia of the People's Republic of China, 2015 ed., 2015, Chinese Medical Science Press.
8. Constantino, M.I., Molyneaux, L., Limacher-Gisler, F., Al-Saeed, A., Luo, C., Wu, T., Twigg, S.M., Yue, D.K., Wong, J., Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 36 (2013), 3863–3869.
9. Datta, K., Franke, T.F., Chan, T.O., Makris, A., Yang, S.I., Kaplan, D.R., Morrison, D.K., Golemis, E.A., Tsichlis, P.N., AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol. Cell. Bio. 15 (1995), 2304–2310.
10. George, S., Rochford, J.J., Wolfrum, C., Gray, S.L., Schinner, S., Wilson, J.C., Soos, M.A., Murgatroyd, P.R., Williams, R.M., Acerini, C.L., Dunger, D.B., Barford, D., Umpleby, A.M., Wareham, N.J., Davies, H.A., Schafer, A.J., Stoffel, M., O'Rahilly, S., Barroso, I., A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304 (2004), 1325–1328.
11. Getz, G.S., Wool, G.D., Reardon, C.A., HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr. Pharm. Des. 16 (2010), 3173–3184.
12. Guo, C., Li, R., Zheng, N., Xu, L., Liang, T., He, Q., Anti-diabetic effect of ramulus mori polysaccharides, isolated from Morus alba L., on STZ-diabetic mice through blocking inflammatory response and attenuating oxidative stress. Int. Immunopharmacol. 16 (2013), 93–99.
13. Hanley, A.J., Williams, K., Stern, M.P., Haffner, S.M., Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care. 25 (2002), 1177–1184.
14. Herling, A.W., Maas, J., Seeger, K., Guidelines for the Care and Use of Laboratory Animals. 1997, Springer Berlin Heidelberg http://link.springer.com/chapter/10.1007/978-3-662-03333-3_14.
15. Howard, B.V., Robbins, D.C., Sievers, M.L., Lee, E.T., Rhoades, D., Devereux, R.B., Cowan, L.D., Gray, R.S., Welty, T.K., Go, O.T., Howard, W.J., LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart study. Arter. Throm. Vas. Biol. 20 (2000), 830–835.
16. Isabelle, M., Lee, B.L., Ong, C.N., Liu, X., Huang, D., Peroxyl radical scavenging capacity, polyphenolics, and lipophilic antioxidant profiles of mulberry fruits cultivated in Southern China. J. Agric. Food Chem. 56 (2008), 9410–9416.
17. Khan, M.A., Rahman, A.A., Islam, S., Khandokhar, P., Parvin, S., Islam, M.B., Hossain, M., Rashid, M., Sadik, G., Nasrin, S., Mollah, M.N., Alam, A.H., A comparative study on the antioxidant activity of methanolic extracts from different parts of Morus alba L. (Moraceae). BMC Res. Notes, 6, 2013, 24.
18. Lapolla, A., Poli, T., Meneghini, F., Zucchetto, M., Franchin, A., Barison, A., Fedele, D., Glycated serum proteins and glucose tolerance. Acta Diabetol. Lat. 25 (1988), 325–332.
19. Lu, J.M., Wang, Y.F., Yan, H.L., Lin, P., Gu, W., Yu, J., Antidiabetic effect of total saponins from Polygonatum kingianum in streptozotocin-induced daibetic rats. J. Ethnopharmacol. 179 (2016), 291–300.
20. Luna, L.G., Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. (III. Blakiston Division), 1968, McGraw-Hill.
21. Mangus, R.S., Fridell, J.A., Kubal, C.A., Davis, J.P., Tector, A.J., Elevated alanine aminotransferase (ALT) in the deceased donor: impact on early post-transplant liver allograft function. Liver Int. 35 (2015), 524–531.
22. Pantalone, K.M., Hobbs, T.M., Wells, B.J., Kong, S.X., Kattan, M.W., Bouchard, J., Yu, C., Sakurada, B., Milinovich, A., Weng, W., Bauman, J.M., Zimmerman, R.S., Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system. BMJ Open Diabetes Res. Care., 3, 2015, e93.
23. Pessin, J.E., Saltiel, A.R., Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest. 106 (2000), 165–169.
24. Perrini, S., Natalicchio, A., Laviola, L., Belsanti, G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., Giorgino, R., Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 53 (2004), 41–52.
25. Ren, C., Zhang, Y., Cui, W., Lu, G., Wang, Y., Gao, H., Huang, L., Mu, Z., A polysaccharide extract of mulberry leaf ameliorates hepatic glucose metabolism and insulin signaling in rats with type 2 diabetes induced by high fat-diet and streptozotocin. Int. J. Biol. Macromol. 72 (2015), 951–959.
26. Rondinone, C., Wang, L.M., Lonnroth, P., Wesslau, C., Pierce, J.H., Smith, U., Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. P. Natl. Acad. Sci. USA. 94 (1997), 4171–4175.
27. Salahuddin, M., Jalalpure, S.S., Antidiabetic activity of aqueous fruit extract of Cucumis trigonus Roxb. in streptozotocin-induced-diabetic rats. J. Ethnopharmacol. 127 (2010), 565–567.
28. Sano, H., Kane, S., Sano, E., Mîinea, C.P., Asara, J.M., Lane, W.S., Garner, C.W., Lienhard, G.E., Insulin-stimulated phosphorylation of a rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278 (2003), 14599–14602.
29. Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52 (2005), 313–320.
30. Stern, R.J., Murphy, E.J., Metformin as initial oral therapy in type 2 diabetes. JAMA-J. Am. Med. Assoc. 313 (2015), 2484–2485.
31. Taniguchi, C.M., Emanuelli, B., Kahn, C.R., Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7 (2006), 85–96.
32. Taskinen, M.R., Smith, U., Lipid disorders in NIDDM: implications for treatment. J. Intern. Med. 244 (1998), 361–370.
33. White, M.F., The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182 (1998), 3–11.
34. Withers, D.J., Burks, D.J., Towery, H.H., Altamuro, S.L., Flint, C.L., White, M.F., Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23 (1999), 32–40.
35. Withers, D.J., Gutierrez, J.S., Towery, H., Burks, D.J., Ren, J.M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., Bonner-Weir, S., White, M.F., Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998), 900–904.
36. Xu, L., Yang, F., Wang, J., Huang, H., Huang, Y., Anti-diabetic effect mediated by Ramulus mori polysaccharides. Carbohyd. Polym. 117 (2015), 63–69.
37. Zhang, Y., Ren, C., Lu, G., Cui, W., Mu, Z., Gao, H., Wang, Y., Purification, characterization and anti-diabetic activity of a polysaccharide from mulberry leaf. Regul. Toxicol. Pharm. 70 (2014), 687–695.